The Epidemiology of Psoriatic Arthritis

Sep 28, 2017 by in RHEUMATOLOGY Comments Off on The Epidemiology of Psoriatic Arthritis

Psoriatic arthritis (PsA) is a chronic systemic inflammatory disorder characterized by joint and entheseal inflammation with a prevalence of 0.05% to 0.25% of the population and 6% to 41% of…

read more

Psoriatic Arthritis

Sep 28, 2017 by in RHEUMATOLOGY Comments Off on Psoriatic Arthritis

Christopher T. Ritchlin, MD, MPH, Editor It is hard to believe that little more than 40 years have elapsed since psoriatic arthritis was first described as a separate entity, HLAB27…

read more

Psoriatic Arthritis

Sep 28, 2017 by in RHEUMATOLOGY Comments Off on Psoriatic Arthritis

Michael H. Weisman, MD, Consulting Editor Chris Ritchlin has done a remarkable job assembling the expertise necessary to put together a timely comprehensive review of Psoriatic Arthritis. We learn how…

read more

Glucocorticoid-induced Osteoporosis

Sep 28, 2017 by in RHEUMATOLOGY Comments Off on Glucocorticoid-induced Osteoporosis

Glucocorticoid-induced osteoporosis (GIOP) is one of the most common and serious adverse effects associated with glucocorticoid use. This article highlights GIOP pathophysiology, epidemiologic associations, effective treatment, and lifestyle modifications that…

read more

Infection Risk and Safety of Corticosteroid Use

Sep 28, 2017 by in RHEUMATOLOGY Comments Off on Infection Risk and Safety of Corticosteroid Use

Corticosteroids are frequently used to treat rheumatic diseases. Their use comes with several well-established risks, including osteoporosis, avascular necrosis, glaucoma, and diabetes. The risk of infection is of utmost concern…

read more

Corticosteroids in Sarcoidosis

Sep 28, 2017 by in RHEUMATOLOGY Comments Off on Corticosteroids in Sarcoidosis

Corticosteroids are the drug of choice for the treatment of sarcoidosis. Because the natural course of sarcoidosis may be self-limiting and/or cause no long-term harm, treatment is not mandatory. Corticosteroids…

read more

Corticosteroids in Myositis and Scleroderma

Sep 28, 2017 by in RHEUMATOLOGY Comments Off on Corticosteroids in Myositis and Scleroderma

Idiopathic inflammatory myopathies (IIMs) involve inflammation of the muscles and are classified by the patterns of presentation and immunohistopathologic features on skin and muscle biopsy into 4 categories: dermatomyositis, polymyositis,…

read more

Corticosteroids for Pain of Spinal Origin

Sep 28, 2017 by in RHEUMATOLOGY Comments Off on Corticosteroids for Pain of Spinal Origin

Targeted interventional delivery of corticosteroids remains a mainstay of treatment for spinal pain syndromes because this approach has a wider therapeutic index than other approaches. The best evidence for analgesic…

read more
Get Clinical Tree app for offline access